Related Experiment Video
Updated: Apr 16, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data
Vivienne A Ezzat1, Victor Lee1, Syed Ahsan1
1The Heart Hospital , London , UK.
Insights
Implantable cardioverter defibrillator (ICD) complication rates vary significantly between randomized controlled trials (RCTs) and registries. Standardizing complication reporting is crucial for accurate patient safety assessments.
Area of Science:
- Cardiology
- Medical Device Technology
- Clinical Research Methodology
Background:
- Implantable cardioverter defibrillators (ICDs) are vital for preventing sudden cardiac death.
- Published complication rates for ICD implantation are inconsistent, necessitating a comprehensive review.
- Existing data lack standardization in complication classification and reporting.
Purpose of the Study:
- To systematically review and meta-analyze complication rates from randomized controlled trials (RCTs) of ICD implantation.
- To compare these findings with contemporary data from a large international registry (NCDR).
- To highlight discrepancies and the need for standardized reporting of ICD complications.
Main Methods:
- Systematic literature search of PubMed for RCTs involving ICD implantation (1999-2013).
- Meta-analysis of 18 RCTs (6433 patients), excluding specific patient groups and procedures.
- Comparison with data from the US National Cardiovascular Data Registry (NCDR) ICD registry (2006-2010).
Main Results:
- Pooled complication rate in RCTs was 9.1% (displacement 3.1%, pneumothorax 1.1%, hematoma 1.2%, infection 1.5%).
- NCDR registry reported a significantly lower major complication rate of 3.08% (displacement 1.02%, hematoma 0.86%, pneumothorax 0.44%).
- No predictors for complications were identified, but longer follow-up showed a trend towards higher rates.
Conclusions:
- RCTs report higher ICD complication rates (9.1%) compared to the NCDR registry (3.08%).
- Discrepancies may stem from under-reporting in registries and variable reporting standards.
- International standardization of ICD complication classification is urgently needed for accurate risk assessment.
Abstract:
Implantable cardioverter defibrillator (ICD) implantation carries a significant risk of complications, however published estimates appear inconsistent. We aimed to present a contemporary systematic review using meta-analysis methods of ICD complications in randomised controlled trials (RCTs) and compare it to recent data from the largest international ICD registry, the US National Cardiovascular Data Registry (NCDR). PubMed was searched for any RCTs involving ICD implantation published 1999-2013; 18 were identified for analysis including 6433 patients, mean follow-up 3 months-5.6 years. Exclusion criteria were studies of children, hypertrophic cardiomyopathy, congenital heart disease, resynchronisation therapy and generator changes. Total pooled complication rate from the RCTs (excluding inappropriate shocks) was 9.1%, including displacement 3.1%, pneumothorax 1.1% and haematoma 1.2%. Infection rate was 1.5%.There were no predictors of complications but longer follow-up showed a trend to higher complication rates (p=0.07). In contrast, data from the NCDR ICD, reporting on 356 515 implants (2006-2010) showed a statistically significant threefold lower total major complication rate of 3.08% with lead displacement 1.02%, haematoma 0.86% and pneumothorax 0.44%. The overall ICD complication rate in our meta-analysis is 9.1% over 16 months. The ICD complication reported in the NCDR ICD registry is significantly lower despite a similar population. This may reflect under-reporting of complications in registries. Reporting of ICD complications in RCTs and registries is very variable and there is a need to standardise classification of complications internationally.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions